Biomass fuel as a risk factor for esophageal squamous cell carcinoma: a systematic review and meta-analysis

Autor: Samson Okello, Suzan Joan Akello, Emmanuel Dwomoh, Emmanuel Byaruhanga, Christopher Kenneth Opio, Ruyang Zhang, Kathleen E. Corey, Winnie R. Muyindike, Ponsiano Ocama, David D. Christiani

Publikováno v: Environmental Health, Vol 18, Iss 1, Pp 1-11 (2019)

Abstract Background The link between use of solid biomass fuel (wood, charcoal, coal, dung, and crop residues) for cooking and/or heating and esophageal squamous cell carcinoma (ESCC) is inconclusive. Objective We systematically reviewed the literatu

Externí odkaz: https://doaj.org/article/fc4693178fcb408a8abbad83695a8463

Leveraging Deep Learning of Chest Radiograph Images to Identify Individuals at High Risk for Chronic Obstructive Pulmonary Disease.

Autor: Doroodgar Jorshery S, Chandra J, Walia AS, Stumiolo A, Corey K, Zekavat SM, Zinzuwadia AN, Patel K, Short S, Mega JL, Plowman RS, Pagidipati N, Sullivan SS, Mahaffey KW, Shah SH, Hernandez AF, Christiani D, Aerts HJWL, Weiss J, Lu MT, Raghu VK

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Nov 15. Date of Electronic Publication: 2024 Nov 15.

Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study.

Autor: Hosny A; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Bitterman DS; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA., Guthier CV; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Qian JM; Harvard Radiation Oncology Program, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Mass General Brigham, Boston, MA., Roberts H; Harvard Radiation Oncology Program, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Mass General Brigham, Boston, MA., Perni S; Harvard Radiation Oncology Program, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Mass General Brigham, Boston, MA., Saraf A; Harvard Radiation Oncology Program, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Mass General Brigham, Boston, MA., Peng LC; Harvard Radiation Oncology Program, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Mass General Brigham, Boston, MA., Pashtan I; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ye Z; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Kann BH; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Kozono DE; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Christiani D; Harvard T H Chan School of Public Health, Massachusetts General Hospital and Harvard Medical School, Baltimore, MD, USA., Catalano PJ; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Aerts HJWL; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, Netherlands., Mak RH; Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: rmak@partners.org.

Publikováno v: The Lancet. Digital health [Lancet Digit Health] 2022 Sep; Vol. 4 (9), pp. e657-e666.

A reply to "Lung cancer outcomes: Are BMI and race clinically relevant?"

Autor: Liu G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada; Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Departments of Medical Biophysics, Pharmacology and Toxicity, and IMS, University of Toronto, Toronto, ON, Canada. Electronic address: Geoffrey.Liu@uhn.ca., Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Chen C; Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Epidemiology and Department of Otolaryngology: Head and Neck Surgery, University of Washington, Seattle, WA, USA., Christiani D; Environmental Health Department, Harvard TH Chan School of Public Health and Harvard Medical School, Boston, MA, USA., Field JK; The Roy Castle Lung Cancer Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK., Hung R; Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Jie Z; Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, USA; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China., Le Marchand L; University of Hawaii Cancer Centre, Honolulu, HI, USA., Ryan B; Centre for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Schabath MB; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Schwartz AG; Barbara Ann Karmanos Cancer Institute, Wayne State University Detroit, MI, USA., Shete S; University of Texas MD Anderson Cancer Center, TX, USA., Shiraishi K; Division of Genome Biology, National Cancer Research Institute, Tokyo, Japan., Tardon A; IUOPA, University of Oviedo and CIBERESP, Oviedo, Spain., Teare MD; University of Sheffield, Sheffield, UK., Yang P; Mayo Clinic, Rochester, MI, USA., Zhang ZF; University of California Los Angeles School of Public Health, CA, USA., Xu W; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada; Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 Apr; Vol. 154, pp. 225-226. Date of Electronic Publication: 2021 Feb 26.

The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients.

Autor: Jiang M; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Fares AF; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada; Hospital de Base, São José do Rio Preto, São Paulo, Brazil., Shepshelovich D; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Yang P; Mayo Clinic, Rochester, MI, USA., Christiani D; Environmental Health Department, Harvard TH Chan School of Public Health and Harvard Medical School, Boston, MA, USA., Zhang J; Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, USA; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China., Shiraishi K; Division of Genome Biology, National Cancer Research Institute, Tokyo, Japan., Ryan BM; Centre for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Chen C; Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Epidemiology and Department of Otolaryngology: Head and Neck Surgery, University of Washington, Seattle, WA, USA., Schwartz AG; Barbara Ann Karmanos Cancer Institute, Wayne State University Detroit, MI, USA., Tardon A; IUOPA, University of Oviedo and CIBERESP, Oviedo, Spain., Shete S; University of Texas MD Anderson Cancer Center, Texas, USA., Schabath MB; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Teare MD; University of Sheffield, Sheffield, UK., Le Marchand L; University of Hawaii Cancer Centre, Honolulu, HI, USA., Zhang ZF; University of California Los Angeles School of Public Health, CA, USA., Field JK; The Roy Castle Lung Cancer Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK., Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Diao N; Environmental Health Department, Harvard TH Chan School of Public Health and Harvard Medical School, Boston, MA, USA., Xie J; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China., Kohno T; Division of Genome Biology, National Cancer Research Institute, Tokyo, Japan., Harris CC; Centre for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Wenzlaff AS; Barbara Ann Karmanos Cancer Institute, Wayne State University Detroit, MI, USA., Fernandez-Tardon G; IUOPA, University of Oviedo and CIBERESP, Oviedo, Spain., Ye Y; University of Texas MD Anderson Cancer Center, Texas, USA., Taylor F; University of Sheffield, Sheffield, UK., Wilkens LR; University of Hawaii Cancer Centre, Honolulu, HI, USA., Davies M; The Roy Castle Lung Cancer Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK., Liu Y; Mayo Clinic, Rochester, MI, USA; PLA Hospital, Beijing, China., Barnett MJ; Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Goodman GE; Swedish Cancer Institute, Seattle, WA, USA., Morgenstern H; Departments of Epidemiology and Environmental Health Sciences, School of Public Health and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA., Holleczek B; Saarland Cancer Registry, Saarbrücken, Germany., Thomas S; Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada., Brown MC; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Hung RJ; Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Xu W; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada; Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Electronic address: Wei.Xu@uhnresearch.ca., Liu G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada; Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Departments of Medical Biophysics, Pharmacology and Toxicity, and IMS, University of Toronto, Toronto, ON, Canada. Electronic address: Geoffrey.liu@uhn.ca.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 Feb; Vol. 152, pp. 58-65. Date of Electronic Publication: 2020 Dec 04.